Hemant Surgical Industries Limited (BOM:543916)
India
· Delayed Price · Currency is INR 100.00
+1.50 (1.52%)
At close: May 5, 2025
BOM:543916 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Revenue | 1,070 | 1,056 | 1,091 | 1,036 | 597.65 | 562.35 |
| Revenue Growth (YoY) | -0.43% | -3.24% | 5.39% | 73.30% | 6.28% | - |
| Cost of Revenue | 763.37 | 782.48 | 815.55 | 824.29 | 478.69 | 437.39 |
| Gross Profit | 306.3 | 273.6 | 275.93 | 211.41 | 118.96 | 124.96 |
| Selling, General & Admin | 127.87 | 120.64 | 111.15 | 79.68 | 57.18 | 63.02 |
| Other Operating Expenses | 69.64 | 48.25 | 59.08 | 68.74 | 26.51 | 27.31 |
| Operating Expenses | 209.57 | 179.15 | 178.73 | 155.91 | 90.03 | 95.27 |
| Operating Income | 96.73 | 94.45 | 97.2 | 55.51 | 28.93 | 29.69 |
| Interest Expense | -12.01 | -9.45 | -16.87 | -16.08 | -18.01 | -15.99 |
| Interest & Investment Income | 11.21 | 11.21 | 5.24 | 1.24 | 1.58 | 1.17 |
| Currency Exchange Gain (Loss) | 13.56 | 13.56 | 14.74 | 4.91 | -4.53 | -8.04 |
| Other Non Operating Income (Expenses) | 3.03 | 8.69 | 0.49 | 2.91 | 2.7 | 1.72 |
| EBT Excluding Unusual Items | 112.51 | 118.46 | 100.8 | 48.48 | 10.67 | 8.55 |
| Gain (Loss) on Sale of Assets | - | - | -0.23 | - | - | - |
| Pretax Income | 121.87 | 127.81 | 100.57 | 61.12 | 15.2 | 8.55 |
| Income Tax Expense | 31.27 | 29.81 | 24.2 | 14.98 | 3.75 | 3.53 |
| Net Income | 90.6 | 98 | 76.37 | 46.14 | 11.45 | 5.01 |
| Net Income to Common | 90.6 | 98 | 76.37 | 46.14 | 11.45 | 5.01 |
| Net Income Growth | 9.89% | 28.32% | 65.52% | 302.86% | 128.42% | - |
| Shares Outstanding (Basic) | 8 | 10 | 7 | 5 | 5 | 5 |
| Shares Outstanding (Diluted) | 8 | 10 | 7 | 5 | 5 | 5 |
| Shares Change (YoY) | 0.56% | 33.66% | 44.60% | - | - | - |
| EPS (Basic) | 11.25 | 9.85 | 10.26 | 8.96 | 2.22 | 0.97 |
| EPS (Diluted) | 11.25 | 9.85 | 10.26 | 8.96 | 2.22 | 0.97 |
| EPS Growth | 9.29% | -4.00% | 14.50% | 303.60% | 128.87% | - |
| Free Cash Flow | - | -130.8 | 23.69 | 116.41 | -26.59 | -10.6 |
| Free Cash Flow Per Share | - | -13.15 | 3.18 | 22.61 | -5.17 | -2.06 |
| Gross Margin | 28.63% | 25.91% | 25.28% | 20.41% | 19.90% | 22.22% |
| Operating Margin | 9.04% | 8.94% | 8.91% | 5.36% | 4.84% | 5.28% |
| Profit Margin | 8.47% | 9.28% | 7.00% | 4.46% | 1.92% | 0.89% |
| Free Cash Flow Margin | - | -12.38% | 2.17% | 11.24% | -4.45% | -1.88% |
| EBITDA | 109.6 | 104.71 | 105.7 | 62.99 | 35.28 | 34.63 |
| EBITDA Margin | 10.25% | 9.92% | 9.68% | 6.08% | 5.90% | 6.16% |
| D&A For EBITDA | 12.87 | 10.26 | 8.5 | 7.49 | 6.34 | 4.95 |
| EBIT | 96.73 | 94.45 | 97.2 | 55.51 | 28.93 | 29.69 |
| EBIT Margin | 9.04% | 8.94% | 8.91% | 5.36% | 4.84% | 5.28% |
| Effective Tax Rate | 25.66% | 23.33% | 24.06% | 24.51% | 24.67% | 41.32% |
| Revenue as Reported | 1,110 | 1,099 | 1,115 | 1,058 | 606.52 | 565.27 |
| Advertising Expenses | - | 5.75 | 9.89 | 2.01 | 1.88 | 3.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.